Monte Rosa Therapeutics Inc (GLUE)
NASDAQ
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Return on Assets (%) | -139.535 | -118.663 | -35.582 | -30.619 | -41.895 |
Return on Equity (%) | 127.428 | 117.876 | -49.506 | -35.061 | -60.068 |
Return on Invested Capital (%) | -235.049 | -227.041 | -40.484 | -36.908 | -65.126 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | 4.804 | 11.291 | 7.468 | 5.503 | 3.575 |
Earnings Per Share | -5.466 | -21.281 | -1.589 | -2.2 | -2.699 |
Cash Per Share | 4.234 | 24.733 | 7.437 | 1.113 | 2.555 |
Working Capital Per Share | 3.861 | 8.491 | 7.135 | 5.075 | 3.782 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | -5.466 | -21.281 | -1.589 | -2.2 | -2.693 |
EBITDA Per Share | -5.466 | -21.281 | -1.589 | -2.2 | -2.693 |
Free Cash Flow Per Share | -4.539 | -19.589 | -1.426 | -2.014 | -2.443 |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A |
Shares Outstanding | 1.42M | 1.69M | 46.54M | 49.32M | 50.14M |
Year End December 30 2023 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | ||||
Shares Outstanding | 49.32M | N/A | N/A | N/A | 50.14M | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | -2996.711 | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | -3004.511 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Market Cap | 399.95M |
Price to Earnings Ratio | -3.14 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 3.31 |
Price to Book Ratio | 2.37 |
Dividend Yield | - |
Shares Outstanding | 61.44M |
Average Volume (1 week) | 1.84M |
Average Volume (1 Month) | 1.76M |
52 Week Change | 24.64% |
52 Week High | 12.40 |
52 Week Low | 3.21 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.